Patients will not be eligible for this study if any of the following in present at the time of study inclusion: <br/ >1. Have pneumonia confirmed by chest imaging. <br/ >2. Patients receiving mechanical ventilation or ECMO or who have multiorgan failure. <br/ >3. Pregnant or lactating females. <br/ >4. Therapy with an investigational agent within the past 30 days from screening. <br/ >5. Treatment with any drug having anti-SARS-CoV-2 activity prior to screening including hydroxychloroquine and other antiviral agents. <br/ >6. Any other conditions, including moderate to severe illness, which would make the patient, in the opinion of the Investigator, unsuitable for the study. <br/ >

Patients will not be eligible for this study if any of the following in present at the time of study inclusion: <br/ >1. Have pneumonia confirmed by chest imaging. <br/ >2. Patients receiving mechanical ventilation or ECMO or who have multiorgan failure. <br/ >3. Pregnant or lactating females. <br/ >4. Therapy with an investigational agent within the past 30 days from screening. <br/ >5. Treatment with any drug having anti-SARS-CoV-2 activity prior to screening including hydroxychloroquine and other antiviral agents. <br/ >6. Any other conditions, including moderate to severe illness, which would make the patient, in the opinion of the Investigator, unsuitable for the study. <br/ >

N/A

N/A

Patients will not be eligible for this study if any of the following in present at the time of study inclusion: <br/ >1. Have pneumonia confirmed by chest imaging. <br/ >2. Patients receiving mechanical ventilation or ECMO or who have multiorgan failure. <br/ >3. Pregnant or lactating females. <br/ >4. Therapy with an investigational agent within the past 30 days from screening. <br/ >5. Treatment with any drug having anti-SARS-CoV-2 activity prior to screening including hydroxychloroquine and other antiviral agents. <br/ >6. Any other conditions, including moderate to severe illness, which would make the patient, in the opinion of the Investigator, unsuitable for the study. <br/ >

Patients will not be eligible for this study if any of the following in present at the time of study inclusion: <br/ >1. Have pneumonia confirmed by chest imaging. <br/ >2. Patients receiving mechanical ventilation or ECMO or who have multiorgan failure. <br/ >3. Pregnant or lactating females. <br/ >4. Therapy with an investigational agent within the past 30 days from screening. <br/ >5. Treatment with any drug having anti-SARS-CoV-2 activity prior to screening including hydroxychloroquine and other antiviral agents. <br/ >6. Any other conditions, including moderate to severe illness, which would make the patient, in the opinion of the Investigator, unsuitable for the study. <br/ >